Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Syros Pharmaceuticals Inc

SYRS
0,2113
0,0046 (2,23%)
25 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/1/202522:49EDGAR2Form 144 - Report of proposed sale of securities
08/1/202522:01EDGAR2Form 8-K - Current report
30/12/202423:11EDGAR2Form 144 - Report of proposed sale of securities
27/12/202422:02EDGAR2Form 144 - Report of proposed sale of securities
13/12/202422:17EDGAR2Form 144 - Report of proposed sale of securities
13/12/202422:09EDGAR2Form 144 - Report of proposed sale of securities
13/12/202422:08EDGAR2Form 144 - Report of proposed sale of securities
06/12/202413:00EDGAR2Form 8-K - Current report
20/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202400:00EDGAR2Form 144 - Report of proposed sale of securities
18/11/202423:42EDGAR2Form 144 - Report of proposed sale of securities
18/11/202423:20EDGAR2Form 144 - Report of proposed sale of securities
18/11/202422:45EDGAR2Form 144 - Report of proposed sale of securities
18/11/202422:18EDGAR2Form 144 - Report of proposed sale of securities
18/11/202418:08EDGAR2Form 144 - Report of proposed sale of securities
18/11/202413:01EDGAR2Form 8-K - Current report
14/11/202423:28EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202423:24EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202423:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202413:00EDGAR2Form 8-K - Current report
12/11/202422:30EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:30BWSyros Announces Topline Data from SELECT-MDS-1 Phase 3 Trial..
04/11/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202412:30BWSyros Reports Third Quarter 2024 Financial Results and..
31/10/202411:49EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
24/10/202413:08BWSyros to Report Third Quarter 2024 Financial Results on..
12/9/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202413:01EDGAR2Form 8-K - Current report
27/8/202413:00BWSyros Pharmaceuticals to Present at Upcoming Medical and..
12/8/202423:03EDGAR2Form 8-K - Current report
12/8/202422:15BWSyros Provides Update on SELECT-AML-1 Phase 2 Clinical Trial
03/8/202400:39EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
31/7/202413:44EDGAR2Form S-8 - Securities to be offered to employees in employee..
31/7/202413:30BWSyros Reports Second Quarter 2024 Financial Results and..
31/7/202412:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
24/7/202413:00BWSyros to Report Second Quarter 2024 Financial Results on..
13/6/202413:00BWSyros to Host Webcast Event on Higher-Risk Myelodysplastic..
07/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:30EDGAR2Form 8-K - Current report
14/5/202413:30BWSyros Reports First Quarter 2024 Financial Results and..
14/5/202412:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202415:00BWSyros to Participate in Upcoming Investor Conferences
07/5/202413:00BWSyros to Report First Quarter 2024 Financial Results on..
09/4/202413:00BWSyros Receives Fast Track Designation from the FDA for..
Apertura: 0,2072 Min: 0,205 Max: 0,214899
Chiusura: 0,2067

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network